254AD9BE-6336-4938-ABFE-8578EC1687B4.jpeg

British researchers have developed a new imaging technology for analyzing tumor biopsies. Furthermore, they claim their Digistain technology enjoys greater reliability compared to subjective diagnoses by human health professionals, according to an article in ScienceDaily.

The Imperial College London (Imperial) research team promised that their new method can reduce the subjectivity and variability often encountered when grading the current stage of a cancer. They published their findings in the journal Convergent Science Physical Oncology.

The biopsy procedure has been used to diagnose cancers for more than a century. In a biopsy, a sample of the tumor is taken, cut into thin slices, and stained with vegetable dyes.

[READ MORE]

You may also like

There is something wrong with Feed URL